http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5535025-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fa048ea1eaabc433bc8e9b069946d62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
filingDate 1978-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_654d2d92b87449193fc99f45a38c80e5
publicationDate 1980-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5535025-A
titleOfInvention Liquid remedy for dermatophytosis and its preparation
abstract PURPOSE:Salicylic acid is dissolved in a specific ointment base consisting of polyethylene glycol and ethanol, whereby the precipitation of the salicylic acid is prevented in the liquid remedy for dermatophytosis. CONSTITUTION:Almost equal amounts of a polyethylene glycol of 3,000-5,000 molecular weight and another polyethylene glycol of 300-500 molecular weight are mixed and about 30wt%, based on the polyethylene glycols, of salicylic acid is added to the mixture and dissolved by heating. Further, about 10wt%, based on the above total amount, of ethanol is added thereto, thus producing said liquid remedy for dermatophytosis. Said preparation is colorless and clear and a little viscous liquid, showing high effectiveness on both dry and wet type dermatophytosis. Since the content of ethanol is reduced, the precipitation of the salicylic acid on the skin can be prevented and the irritating property also is inhibited.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-780838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6333331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6089145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02078669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6787148-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5108741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1214925-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0113877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1214925-A1
priorityDate 1978-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID101202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID101202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 29.